Consumer Goods: COVID-19 Was a Wake-Up Call for Antimicrobial Claims Management

For Consumer Goods companies that manufacture and sell antimicrobial products, the COVID-19 pandemic has heightened the sense of urgency around getting new efficacy claims substantiated, approved, and in-market quickly.

Connect with a Specialist

Ready to explore how Veeva can help you transform your organization?

Try Veeva Meet us in Person